Yellow fever as well as larvae-eating fish and copepods, which reduce the number of larvae. For many years, copepods of the genus "Mesocyclops" have been used in Vietnam for preventing dengue fever. It eradicated the mosquito vector in several areas. Similar efforts may be effective against yellow fever. Pyriproxyfen is recommended as a chemical larvicide, mainly because it is safe for humans and effective even in small doses. The second strategy is to reduce populations of the adult yellow fever mosquito. Lethal ovitraps can reduce "Aedes" populations, but with a decreased amount of pesticide because it targets the mosquitoes directly. Curtains and
Yellow fever probably due to the genetic morphology of the immune system. Another possible side effect is an infection of the nervous system, which occurs in one in 200,000 to 300,000 cases, causing yellow fever vaccine-associated neurotropic disease, which can lead to meningoencephalitis and is fatal in less than 5% of cases. The Yellow Fever Initiative, launched by WHO in 2006, vaccinated more than 105 million people in 14 countries in West Africa. No outbreaks were reported during 2015. The campaign was supported by the GAVI Alliance, and governmental organizations in Europe and Africa. According to the WHO, mass vaccination cannot eliminate